Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Amortization of Goodwill (2020)

Historic Amortization of Goodwill for Angiodynamics (ANGO) over the last 1 years, with Q2 2020 value amounting to $158.6 million.

  • Angiodynamics' Amortization of Goodwill changed N/A to $158.6 million in Q2 2020 from the same period last year, while for May 2020 it was $158.6 million, marking a year-over-year change of. This contributed to the annual value of $159.5 million for FY2024, which is 99613.03% up from last year.
  • Per Angiodynamics' latest filing, its Amortization of Goodwill stood at $158.6 million for Q2 2020.
  • Angiodynamics' 5-year Amortization of Goodwill high stood at $158.6 million for Q2 2020, and its period low was $158.6 million during Q2 2020.